Have your own idea? Try our Stock Screener
UPDATED Feb 20, 2025
Discover large cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
500420 | ₹3,094.55 | 0.6% | 18.6% | ₹1.0t | ₹3,639.83 | PE56.2x | E23.3% | 0.9% | ||
AVTR | US$17.49 | -3.4% | -28.9% | US$12.0b | US$24.85 | PE16.7x | E-2.9% | n/a | ||
603392 | CN¥68.50 | -0.04% | -2.4% | CN¥87.0b | CN¥61.40 | PS34.8x | E109.4% | 0.5% | ||
REC | €54.85 | -10.0% | 6.1% | €11.2b | €58.19 | PE26.9x | E11.9% | 2.2% | ||
NBIX | US$116.11 | -0.7% | -12.9% | US$11.4b | US$166.45 | PE33.9x | E27.1% | n/a | ||
500124 | ₹1,170.90 | -4.3% | -8.0% | ₹975.5b | ₹1,347.43 | PE18.2x | E-0.9% | 0.7% | ||
MANKIND | ₹2,348.45 | -6.1% | 7.3% | ₹968.9b | ₹2,818.25 | PE47.5x | E17.5% | n/a | ||
MEDP | US$344.85 | 0.7% | -12.4% | US$10.5b | US$342.93 | PE26x | E9.5% | n/a | ||
ZYDUSLIFE | ₹899.65 | -4.6% | -0.5% | ₹905.3b | ₹1,075.23 | PE20x | E-1.8% | 0.3% | ||
500257 | ₹1,977.60 | -3.8% | 24.1% | ₹902.7b | ₹2,283.80 | PE31.5x | E14.7% | 0.4% | ||
TECH | US$65.49 | -1.9% | -8.7% | US$10.4b | US$85.42 | PE65.5x | E21.9% | 0.5% | ||
PCVX | US$82.47 | -1.6% | 11.6% | US$10.4b | US$149.89 | PB3x | E29.3% | n/a | ||
SRPT | US$108.41 | -1.0% | -19.6% | US$10.2b | US$181.78 | PE85x | E30.1% | n/a | ||
SOBI | SEK 315.80 | -2.4% | 19.1% | SEK 108.5b | SEK 368.42 | PE27.9x | E17.2% | n/a | ||
688506 | CN¥209.43 | 14.7% | 80.9% | CN¥73.5b | CN¥278.91 | PE22.1x | E-96.6% | 0% | ||
EXEL | US$35.09 | 1.7% | 69.4% | US$9.8b | US$36.89 | PE18.8x | E20.0% | n/a | ||
ERF | €49.44 | -2.1% | -14.0% | €9.3b | €58.39 | PE26.1x | E18.5% | 1.2% | ||
IPN | €109.10 | -3.4% | 4.2% | €9.0b | €127.60 | PE25.2x | E14.6% | 1.3% | ||
EXAS | US$49.51 | -2.1% | -16.8% | US$9.3b | US$70.58 | PS3.3x | E86.0% | n/a | ||
ASND | US$154.58 | 8.5% | -2.3% | US$9.3b | US$202.83 | PS24.2x | E58.7% | n/a | ||
300122 | CN¥26.85 | 5.3% | -49.4% | CN¥62.6b | CN¥34.93 | PE17.4x | E33.2% | 3.0% | ||
600196 | CN¥25.63 | 0.8% | 6.5% | CN¥62.0b | CN¥25.83 | PE32.2x | E23.8% | 1.1% | ||
QGEN | US$38.57 | -3.7% | -13.9% | US$8.5b | US$49.83 | PE99.7x | E27.2% | 3.3% | ||
RGEN | US$162.67 | 11.3% | -15.9% | US$8.4b | US$192.50 | PS14.4x | E43.2% | n/a |